Table 4.
Comparison of CAD-related indicators among groups of non-CAD, premenopausal CAD and postmenopausal CAD
| Indicators | Non-CAD group | Premenopausal CAD group | Postmenopausal CAD group |
|---|---|---|---|
| SBP (mm Hg) | 123.0 ± 14.7 | 134.9 ± 16.3a | 140.5 ± 18.1a,b |
| DBP (mm Hg) | 80.5 ± 9.2 | 83.8 ± 10.5 | 82.6 ± 9.7 |
| Heart rate (/min) | 86 ± 10 | 88 ± 17 | 88 ± 14 |
| FBG (mmol/L) | 7.6 ± 1.5 | 9.3 ± 0.8 | 10.4 ± 1.3 |
| 2 h PG (mmol/L) | 12.3 ± 1.9 | 15.2 ± 2.3 | 15.9 ± 2.1 |
| BUN (mmol/L) | 6.9 ± 1.6 | 7.7 ± 2.7 | 8.2 ± 3.5 |
| Cr (μmol/L) | 76.7 ± 16.5 | 84.1 ± 24.1 | 88.8 ± 21.9 |
| CysC (mg/dL) | 1.1 ± 0.2 | 1.4 ± 0.3a | 1.8 ± 0.2a,b |
| hs-CRP (mg/L) | 0.7 ± 0.2 | 12.8 ± 8.3a | 16.5 ± 7.9a,b |
| TC (mmol/L) | 4.4 ± 0.7 | 4.7 ± 1.1 | 4.6 ± 0.8 |
| TG (mmol/L) | 1.7 ± 0.1 | 1.8 ± 0.7a | 2.1 ± 0.6a,b |
| HDL-C (mmol/L) | 1.4 ± 0.3 | 1.2 ± 0.1 | 1.4 ± 0.3 |
| LDL-C (mmol/L) | 2.4 ± 0.9 | 3.2 ± 0.6a | 3.9 ± 0.7a,b |
acompared with non-CAD group
bcompared with pre-menopausal CAD group